Mr.Xu specializes in providing legal services for innovative high-tech enterprises and their founders. His service scope includes company establishment, equity structure design and restructuring, equity financing, investment and M&A, equity incentive, shareholder dispute resolution and company governance compliance. The client's industriess include biomedicine, medical devices, integrated circuit semiconductors, new energy and new materials. Mr.Xu provides customers with efficient and executable solutions based on the their business development stages, combined with the industries characteristics of and professional legal knowledge.
Practice Areas
Investment and Financing, Mergers & Acquisitions, Equity Incentive, Corporate Governance and Compliance
Representative Transactions
Equity Financing
Providing different rounds of equity financing, transaction structure design, due diligence assistance, transaction document modification and negotiation, delivery assistance and other legal services for innovative high-tech enterprises and their founders, including but not limited to Suzhou BlueHorse Therapeutics, Raymon Pharmaceuticals, GenHouse Pharmaceutical, Etta Biotech, Yuzhibo Biologial, Helios-Huaming BioPharma, Asocura Pharmaceuticals, RainSure biology, Wushuang Medical Equipment, Raynor Medical, Attogen Biomedical, Biortus Biosciences, KMQ BioTech, Simatech Incorporation, Sinat Biotechnology, Everest Semiconductor, MIX-DESIGN SEMICONDUCTOR, Hanano Materials, Suzhou Creative Nano-Carbon, Inn-Mag New Energy, Chuangsheng Photoelectric Technology.
Equity investment and M&A:
Outbound investment and establishment of joint ventures for CareRay Digital Medical Technology
Everbright Environmental Protection Group preliminary asset acquisition of Jiangsu Clean Environment
The investment project of Huarong group for Anhui lifeng group.
The investment project of Huacheng gas for Taicang suchuang energy.
The acquisition of Rugao commercial complex by Jinxincheng group.
The equity acquisition about Yizheng haili petroleum.
The capital increase project of Shanghai chong yuan for xi ying zhou
List in National Equities Exchange and Quotations about Hangzhou Sangni energy.
Registration of private fund managers.
Fund raising and establishment.
Equity Incentive:
Acting as lead partner to provide stock-ownership incentive for many enterprises, such as YW MEMS, Beaver biology, Hechuan Chemical, Fengyuan medical treatment, Galaxy biology, Yacoo Science, Shanghai SOOYAN Intelligent, Dmetrix, iayu Biomedical, Fosun Orinove, eKontrol Drive, baizhitong, Attogen Biomedical, whalesgame, Kmerit, Yuelu thermoplastic, Mix-Design.
Corporate Governance and Compliance
Acting as lead partner to provide perennial legal services and compliance management for innovative high-tech enterprises and industrial park customers at different development stages. Customers include BioBAY, Nanopolis, SISPARK, Adock, CareRay Digital Medical (STAR Market), Asieris Pharmaceuticals (STAR Market), Touchstone International Medical (STAR Market), Adagene (NASDAQ), Dawnrays (SEHK), Youseen New Drug, Lexenpharm, GenHouse Pharmaceutical, Abogen Biosciences, Fosun Ade, Lisure Science, Rainmed Medical, ProfoundBio, Lavamed, Advanced Technology Research, IMotion Automotive Technology, Everest Semiconductor.
Bar Admissions
People's Republic of China, 2017
Professional Experience
Guantao Law Firm, Partner (since August 2019)
Guantao Law Firm, Paralegal, Lawyer(July 2016 - August 2019)
Education
MA, Suzhou University (2013-2016)
BA, Northwest University of Politics and Law (2009-2013)